Daly Timothy 4
4 · Ovid Therapeutics Inc. · Filed Dec 21, 2020
Insider Transaction Report
Form 4
Daly Timothy
VP, Finance & Corp. Controller
Transactions
- Award
Stock Option (Right to Buy)
2020-12-17+125,000→ 125,000 totalExercise: $2.82Exp: 2030-12-16→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.